SHARING IDEAS THAT DO GOOD

Aussie biotech addressing sepsis with new diagnostic

post-image
Australian company Microbio has been awarded a Federal Government Accelerating Commercialisation Grant to commercialise a new diagnostic assay to rapidly identify 26 of the most common pathogens that cause bloodstream infections and sepsis. The InfectID-Blood Stream Infection (BSI) diagnostic assay is a real-time Polymerase Chain Reaction (PCR) identifies the pathogen causing the infection in about two hours to enable patients to be treated with targeted antimicrobials in a timely manner. Sepsis kills around 11 million people around the world each year. | https://microbio.com.au/news-and-events/ 
What do you think?

You must be logged in to post a comment.
Comments

Related Posts

Healthcare

post-image

Dietary fibre supplement may help manage Type I Diabetes
27 July 2021 by Mel Raassina 0 Comments
 

Healthcare

post-image

New generation anti-cancer drug for children with brain tumours shows promise
9 July 2021 by Mel Raassina 0 Comments

Healthcare

post-image

Faster bone repair - yes, pls
6 July 2021 by Kylie Hargrea... 0 Comments